An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, positive reviews and detailed instructions for mixing or injecting at home.
Within minutes of joining one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, health issues or previous experience.
Item Information and Pricing
Inside these communities, messages display black plastic parcels with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.
